LAVA Therapeutics (LVTX) Short Interest Ratio & Short Volume $1.16 +0.07 (+6.42%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LAVA Therapeutics Short Interest DataLAVA Therapeutics (LVTX) has a short interest of 137,100 shares, representing 1.05% of the float (the number of shares available for trading by the public). This marks a -28.41% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 163,011 shares to cover all short positions.Current Short Interest137,100 sharesPrevious Short Interest191,500 sharesChange Vs. Previous Month-28.41%Dollar Volume Sold Short$174,117.00Short Interest Ratio0.3 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares26,305,000 sharesFloat Size13,020,000 sharesShort Percent of Float1.05%Today's Trading Volume71,624 sharesAverage Trading Volume163,011 sharesToday's Volume Vs. Average44% Short Selling LAVA Therapeutics? Sign up to receive the latest short interest report for LAVA Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLVTX Short Interest Over TimeLVTX Days to Cover Over TimeLVTX Percentage of Float Shorted Over Time Remove Ads LAVA Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025137,100 shares $174,117.00 -28.4%1.1%0.3 $1.27 3/15/2025191,500 shares $248,950.00 -50.6%1.5%0.5 $1.30 2/28/2025387,300 shares $499,617.00 +1,443.0%3.0%0.9 $1.29 2/15/202525,100 shares $23,591.49 -17.2%0.2%0.1 $0.94 1/31/202530,300 shares $29,694.00 -50.3%0.2%0.3 $0.98 1/15/202561,000 shares $59,170.00 +34.1%0.4%0.5 $0.97 12/31/202445,500 shares $43,270.50 -22.5%0.3%0.4 $0.95 12/15/202458,700 shares $65,157.00 +178.2%0.4%0.7 $1.11 11/30/202421,100 shares $33,760.00 -20.1%0.2%0.3 $1.60 11/15/202426,400 shares $41,448.00 +38.2%0.2%0.6 $1.57 Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/202419,100 shares $34,571.00 +695.8%0.1%0.4 $1.81 10/15/20242,400 shares $3,840.00 -75.5%0.0%0 $1.60 9/30/20249,800 shares $16,268.00 -69.9%0.1%0.2 $1.66 9/15/202432,500 shares $55,900.00 -28.4%0.2%0.5 $1.72 8/31/202445,400 shares $79,450.00 -20.9%0.3%0.7 $1.75 8/15/202457,400 shares $104,468.00 +36.7%0.4%0.8 $1.82 7/31/202442,000 shares $89,880.00 -20.6%0.3%0.6 $2.14 7/15/202452,900 shares $95,220.00 -30.2%0.4%0.7 $1.80 6/30/202475,800 shares $136,440.00 -5.5%0.5%0.8 $1.80 6/15/202480,200 shares $187,668.00 -4.8%0.6%0.6 $2.34 5/31/202484,200 shares $190,292.00 -29.0%0.6%0.4 $2.26 5/15/2024118,500 shares $335,355.00 -2.3%0.8%0.1 $2.83 4/30/2024121,300 shares $350,557.00 -37.4%0.9%0.1 $2.89 4/15/2024193,800 shares $567,834.00 -8.4%1.4%0.1 $2.93 3/31/2024211,600 shares $704,628.00 -34.3%1.5%0.1 $3.33 3/15/2024322,100 shares $950,195.00 +476.2%2.3%0.2 $2.95 2/29/202455,900 shares $186,147.00 +448.0%0.5%0 $3.33 2/15/202410,200 shares $20,604.00 -88.4%0.1%0 $2.02 1/31/202487,700 shares $146,459.00 +853.3%0.7%0.1 $1.67 1/15/20249,200 shares $15,364.00 +15.0%0.1%0.3 $1.67 12/31/20238,000 shares $12,640.00 -27.3%0.1%0.2 $1.58 12/15/202311,000 shares $17,160.00 -9.8%0.1%0.4 $1.56 11/30/202312,200 shares $18,492.76 -28.7%0.1%0.4 $1.52 11/15/202317,100 shares $25,480.71 -21.6%0.1%0.6 $1.49 10/31/202321,800 shares $25,942.00 -25.3%0.2%0.7 $1.19 10/15/202329,200 shares $40,588.00 -20.4%0.3%1.4 $1.39 9/30/202336,700 shares $53,949.00 -3.2%0.3%1.4 $1.47 9/15/202337,900 shares $64,759.73 -15.0%0.3%1.1 $1.71 8/31/202344,600 shares $78,942.00 +34.7%0.4%0.7 $1.77 8/15/202333,100 shares $59,580.00 -32.0%0.3%0.1 $1.80Why War with China Start in 128 Days (Ad)The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we believe are in immediate danger.There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K, 7/31/202348,700 shares $91,556.00 -45.2%0.4%0.1 $1.88 7/15/202388,900 shares $176,022.00 +95.4%0.8%0.1 $1.98 6/30/202345,500 shares $92,365.00 -50.7%0.5%0.1 $2.03 6/15/202392,300 shares $180,908.00 +709.7%0.9%0.1 $1.96 5/31/202311,400 shares $21,660.00 -46.2%0.1%0 $1.90 5/15/202321,200 shares $40,280.00 +50.4%0.2%0.4 $1.90 4/30/202314,100 shares $21,291.00 +95.8%0.2%0.2 $1.51 4/15/20237,200 shares $12,816.00 -30.1%0.1%0.1 $1.78 3/31/202310,300 shares $17,098.00 -40.1%0.1%0.2 $1.66 3/15/202317,200 shares $29,584.00 +177.4%0.2%0.3 $1.72 2/28/20236,200 shares $13,888.00 +40.9%0.1%0.1 $2.24 2/15/20234,400 shares $14,872.00 -17.0%0.0%0.1 $3.38 1/31/20235,300 shares $19,292.00 +35.9%0.0%0.2 $3.64 1/15/20233,900 shares $15,015.00 -38.1%0.0%0.1 $3.85 12/30/20226,300 shares $22,050.00 +34.0%0.0%0.1 $3.50 12/15/20224,700 shares $18,142.00 -78.3%0.0%0 $3.86 11/30/202221,700 shares $119,567.00 +130.9%0.1%0 $5.51 11/15/20229,400 shares $50,196.00 No Change0.0%0 $5.34 10/31/20229,400 shares $40,702.00 +213.3%0.0%0 $4.33 10/15/20223,000 shares $11,880.00 -98.1%0.0%0 $3.96 9/30/2022158,800 shares $725,716.00 +14,336.4%1.7%0.2 $4.57 9/15/20221,100 shares $2,574.00 -31.3%0.0%0 $2.34 8/31/20221,600 shares $4,080.00 -36.0%0.0%0.3 $2.55 8/15/20222,500 shares $6,275.00 -30.6%0.0%0.3 $2.51 7/31/20223,600 shares $9,360.00 +71.4%0.0%0.4 $2.60 7/15/20222,100 shares $5,544.00 +2,000.0%0.0%0.3 $2.64 6/30/2022100 shares $295.00 -85.7%N/A0 $2.95 6/15/2022700 shares $1,995.00 -30.0%0.0%0.1 $2.85 5/31/20221,000 shares $3,000.00 -58.3%0.0%0.1 $3.00 5/15/20222,400 shares $9,528.00 +200.0%0.0%0.3 $3.97 4/30/2022800 shares $3,256.00 +14.3%0.0%0.1 $4.07 4/15/2022700 shares $2,961.00 -41.7%0.0%0.1 $4.23 3/31/20221,200 shares $5,280.00 +20.0%0.0%0.1 $4.40 3/15/20221,000 shares $4,360.00 +11.1%0.0%0.1 $4.36 2/28/2022900 shares $4,122.00 -66.7%0.0%0 $4.58 2/15/20222,700 shares $13,527.00 -55.0%0.0%0.1 $5.01 1/31/20226,000 shares $33,120.00 -3.2%0.1%0.3 $5.52 1/15/20226,200 shares $30,938.00 -55.1%0.1%0.3 $4.99 12/31/202113,800 shares $75,900.00 -9.8%0.2%0.4 $5.50 12/15/202115,300 shares $78,030.00 -58.8%0.2%0.4 $5.10 11/30/202137,100 shares $257,474.00 -28.2%0.4%0.9 $6.94 11/15/202151,700 shares $362,934.00 -22.4%0.6%1.3 $7.02 10/29/202166,600 shares $507,492.00 -29.6%0.7%1.4 $7.62 10/15/202194,600 shares $674,498.00 +26.8%1.0%0.6 $7.13 9/30/202174,600 shares $441,632.00 +1.2%0.8%0.5 $5.92 9/15/202173,700 shares $467,258.00 +18.1%0.8%0.5 $6.34 8/31/202162,400 shares $408,720.00 +2.1%0.7%0.5 $6.55 8/13/202161,100 shares $348,881.00 No Change0.7%0.5 $5.71 LVTX Short Interest - Frequently Asked Questions What is LAVA Therapeutics' current short interest? Short interest is the volume of LAVA Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 137,100 shares of LVTX short. 1.05% of LAVA Therapeutics' shares are currently sold short. Learn More on LAVA Therapeutics' current short interest. Which institutional investors are shorting LAVA Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of LAVA Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for LAVA Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.05% of LAVA Therapeutics' floating shares are currently sold short. Is LAVA Therapeutics' short interest increasing or decreasing? LAVA Therapeutics saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 137,100 shares, a decline of 28.4% from the previous total of 191,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is LAVA Therapeutics' float size? LAVA Therapeutics currently has issued a total of 26,305,000 shares. Some of LAVA Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LAVA Therapeutics currently has a public float of 13,020,000 shares. How does LAVA Therapeutics' short interest compare to its competitors? 1.05% of LAVA Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to LAVA Therapeutics: Larimar Therapeutics, Inc. (7.83%), Neurogene Inc. (19.85%), scPharmaceuticals Inc. (10.20%), Organigram Holdings Inc. (7.34%), ADC Therapeutics SA (4.63%), Kodiak Sciences Inc. (6.56%), Tonix Pharmaceuticals Holding Corp. (13.37%), Compugen Ltd. (2.40%), Nkarta, Inc. (12.18%), Elutia Inc. (0.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short LAVA Therapeutics stock? Short selling LVTX is an investing strategy that aims to generate trading profit from LAVA Therapeutics as its price is falling. LVTX shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against LAVA Therapeutics? A short squeeze for LAVA Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LVTX, which in turn drives the price of the stock up even further. How often is LAVA Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LVTX, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Larimar Therapeutics Short Interest Neurogene Short Interest scPharmaceuticals Short Interest Organigram Short Interest ADC Therapeutics Short Interest Kodiak Sciences Short Interest Tonix Pharmaceuticals Short Interest Compugen Short Interest Nkarta Short Interest Elutia Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LVTX) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredDOGE’s 690% winning stockElon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LVTX Stock Free LVTX Stock Alerts